BOSCIA, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 1.832
AS - Asia 998
EU - Europa 724
SA - Sud America 213
Continente sconosciuto - Info sul continente non disponibili 140
AF - Africa 55
OC - Oceania 1
Totale 3.963
Nazione #
US - Stati Uniti d'America 1.721
SG - Singapore 475
IT - Italia 335
BR - Brasile 163
HK - Hong Kong 129
CN - Cina 123
VN - Vietnam 97
RU - Federazione Russa 91
DE - Germania 81
FR - Francia 53
CA - Canada 45
GB - Regno Unito 32
IN - India 31
BD - Bangladesh 29
NL - Olanda 23
FI - Finlandia 20
AR - Argentina 19
PL - Polonia 16
ZA - Sudafrica 15
MX - Messico 14
ID - Indonesia 13
IQ - Iraq 13
JP - Giappone 13
ES - Italia 12
CR - Costa Rica 11
PK - Pakistan 11
IL - Israele 10
SA - Arabia Saudita 9
VE - Venezuela 9
AT - Austria 8
CO - Colombia 8
SC - Seychelles 8
SE - Svezia 8
TR - Turchia 8
NI - Nicaragua 7
PH - Filippine 7
TT - Trinidad e Tobago 7
UA - Ucraina 7
BE - Belgio 6
HN - Honduras 6
LT - Lituania 6
MA - Marocco 6
SV - El Salvador 6
CL - Cile 5
EG - Egitto 5
CH - Svizzera 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
TH - Thailandia 4
TN - Tunisia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CW - ???statistics.table.value.countryCode.CW??? 3
EC - Ecuador 3
ET - Etiopia 3
KE - Kenya 3
PT - Portogallo 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GP - Guadalupe 2
GR - Grecia 2
GT - Guatemala 2
IE - Irlanda 2
KZ - Kazakistan 2
NG - Nigeria 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CU - Cuba 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KR - Corea 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MR - Mauritania 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
RE - Reunion 1
Totale 3.823
Città #
Ashburn 329
Singapore 270
San Jose 252
Hong Kong 126
Elk Grove Village 91
Milan 82
Council Bluffs 64
Beijing 59
Los Angeles 55
Dallas 43
New York 42
Buffalo 36
Santa Clara 36
Rome 35
Lauterbourg 34
Ho Chi Minh City 33
Columbus 27
Falkenstein 27
Boardman 23
Hanoi 22
Munich 22
Phoenix 19
São Paulo 18
Bari 17
Atlanta 15
Frankfurt am Main 15
Warsaw 15
Helsinki 14
Brooklyn 13
Orem 13
Montreal 12
Tokyo 12
Jakarta 11
Chicago 10
Toronto 10
San José 9
Amsterdam 8
Houston 8
Johannesburg 8
London 8
Mexico City 8
Stockholm 8
Washington 8
Denver 7
Figino 7
Managua 7
Naples 7
North Bergen 7
Turin 7
Belo Horizonte 6
Chennai 6
Nuremberg 6
Poplar 6
San Salvador 6
Seattle 6
Baghdad 5
Brussels 5
Campinas 5
Carmiano 5
Fortaleza 5
Hải Dương 5
Moscow 5
Palermo 5
Pittsburgh 5
Rio de Janeiro 5
Abidjan 4
Casamassima 4
Charlotte 4
Da Nang 4
Dhaka 4
Jeddah 4
Lahore 4
Madrid 4
Manchester 4
Memphis 4
Philadelphia 4
Portsmouth 4
Queens 4
Shanghai 4
Tashkent 4
Vienna 4
Acalanes Ridge 3
Addis Ababa 3
Ankara 3
Birmingham 3
Bogotá 3
Bologna 3
Boston 3
Brasília 3
Brno 3
Calgary 3
Casablanca 3
Cleveland 3
Curitiba 3
Detroit 3
Düsseldorf 3
Espoo 3
Guarulhos 3
Hillsboro 3
Joinville 3
Totale 2.216
Nome #
FUNCTIONAL AND ANATOMICAL OUTCOMES AFTER SHORT-TERM HEAVY SILICONE OIL ENDOTAMPONADE FOR INFERIOR RHEGMATOGENOUS RETINAL REDETACHMENT: A Pilot Study 137
Anterior chamber bleeding due to intravitreal dexamethasone implant sclerotomy without vitreous hemorrhage 123
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD 118
Biofeedback Training after Successful Inverted Internal Limiting Membrane (ILM)-Flap Technique for High Myopic Macular Hole 116
Long-Term Impact of Diabetic Retinopathy on Response to Anti-VEGF Treatment in Neovascular AMD 112
Evaluation of the Efficacy of Ozonated Oil in Liposomes as an Adjuvant in Intravitreal Injection Prophylaxis: OPERA Study 111
Micropulse Laser versus Eplerenone for Chronic Central Serous Chorioretinopathy: A 12-Month Comparison 107
Comparative Study on Anti-VEGF in Wet Age-Related Macular Degeneration in the Setting Based on Lean Methodology from the Bari Intravitreal Injection Registry (BIVIR) 105
Neurovascular retinal impairment in early-treated adults with phenylketonuria 104
Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME) 104
Analysis of Choriocapillaris Reperfusion Topography Following Faricimab Treatment for Neovascular Age-Related Macular Degeneration in Therapy-Naïve Patients 103
Liposomal Ozonated Oil Ensures a Further Reduction in the Microbial Load Before Intravitreal Injection: the "OPERA" Study 101
Continuous Eplerenone Treatment in Chronic Central Serous Chorioretinopathy: Long-Term Results from a Pilot Study 98
Effect of Pro Re Nata Regimen with Anti-VEGF on Type 3 Macular Neovascularization: Long-Term Outcomes 98
Topographical Quantification of Hyper-Reflective Foci May Predict the Development of Macular Atrophy in Patients With Neovascular Age-Related Macular Degeneration 95
Immediate effect of anti-VEGF injections on optic nerve head: Correlation between intraocular pressure and anatomical peripapillary changes 95
Analysis of Choriocapillaris Reperfusion Topography following Faricimab Treatment for Neovascular Age-Related Macular Degeneration in Non-Treatment-Naïve Patients 95
Photobiomodulation-induced choriocapillaris perfusion enhancement and outer retinal remodelling in intermediate age-related macular degeneration: a promising therapeutic approach with short-term results 95
Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization 92
Xen gel stent implant for persistent glaucoma after silicone oil removal 92
Choriocapillaris flow in two different patterns of exudative type 1 macular neovascularization 90
Multifocal Electroretinography Changes in Patients with Late-Stage Age-Related Macular Degeneration (AMD) After Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT): A Case Series 89
SEVERE VISUAL LOSS DURING ANTI-VEGF INTRAVITREAL INJECTIONS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Timing, Prognosis and Optical Coherence Tomography Findings 87
Microperimetric evaluation and predictive factors of visual recovery after successful inverted internal limiting membrane-flap technique for macular hole in high myopic eyes 87
Choriocapillaris Reperfusion in Resolved Chronic Central Serous Chorioretinopathy Treated with Eplerenone: Long-Term Effects on the Fellow Eye 82
Twelve-Month Outcomes and Optical Coherence Tomography (OCT) Biomarkers After Intravitreal Dexamethasone Implantation in Pseudophakic Eyes with Post-Vitrectomy Cystoid Macular Edema (CME)—Refractory to Medical Therapy 79
LONG-TERM VISUAL OUTCOMES AND OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION FOLLOWING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY 77
Subthreshold micropulse laser treatment for autosomal recessive bestrophinopathy complicated by macular neovascularization 77
Long-term Eplerenone treatment in chronic central serous chorioretinopathy: effects on affected and fellow eye 71
Short-term peripapillary structural and vascular changes following anti-VEGF vs. Dexamethasone intravitreal therapy in patients with DME 70
Factors influencing the number of anti-VEGF injections in myopic choroidal neovascularization: a multicenter study 69
Intraoperative OCT-Guided Selective Epiretinal Membrane (ERM) Peeling Versus ERM and Internal Limiting Membrane Peeling for Tractional Macular Edema in Diabetic Eyes 68
INTERSESSION REPEATABILITY OF READING PERFORMANCE MEASURES IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 66
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the Literature 66
The Impact of Diabetic Retinopathy on the Choriocapillaris in Neovascular AMD 66
Optical coherence tomography biomarkers indicating visual enhancement in diabetic macular edema resolved through anti-VEGF therapy 65
Intravitreal Dexamethasone Implant in Vitreoretinal Surgery: An Overview of the Literature 61
Relationship of Topographic Distribution of Macular Atrophy Secondary to Neovascular AMD and Reading Performance 58
Visual and anatomical evaluation of navigated subthreshold micropulse laser versus photodynamic therapy in managing chronic central serous chorioretinopathy 55
Ellipsoid zone reflectivity changes after idiopathic epiretinal membrane peeling: a pilot study 55
Optimizing resolution for type 1 macular neovascularization detection in pachychoroid disease: A 3 × 3 vs 6 × 6 mm SS-OCTA comparative study 54
Comparison of Rescue Approach with Gore-Tex Suture Scleral Fixation and Lens Explantation Combined with Standardized Flanged Intrascleral Fixation 48
Recalcitrant macular edema after pseudophakic rhegmatogenous retinal detachment repair: risk factors and response to intravitreal dexamethasone implant 47
RWC Update: Uveal Effusion Syndrome; Peeling the Internal Limiting Membrane in Epiretinal Membrane Surgery; Partially Scrambled Best Disease 46
Choroidal Layer Analysis Under Flat Irregular Pigment Epithelial Detachments in Central Serous Chorioretinopathy 42
Choroidal Remodeling After Subthreshold Micropulse Laser in Chronic Central Serous Chorioretinopathy: Short-Term Outcomes 38
Evaluation of choriocapillaris perfusion changes in chronic central serous chorioretinopathy following Half-Dose photodynamic therapy 34
Impact of diabetes and diabetic retinopathy on neovascular exudative age‐related macular degeneration 30
Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration 28
Amniotic Membrane-Assisted Corneal Transplantation in Ocular Perforation Due to GVHD: A Case Report 21
The prognostic role of video head-impulse test in the clinical evaluation of chronic vestibular damage: A brief case series 19
Pachychoroid disease spectrum: how multimodal imaging and OCT angiography have improved our knowledge 17
Totale 3.963
Categoria #
all - tutte 12.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 0 0 0 0 0 0 0 6
2023/202433 1 4 1 7 3 3 0 2 0 8 0 4
2024/2025641 16 0 6 25 12 82 68 81 48 53 97 153
2025/20262.373 274 86 98 162 378 224 203 111 354 238 67 178
2026/2027910 122 101 277 385 25 0 0 0 0 0 0 0
Totale 3.963